Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Carcinoma, Hepatocellular × Ipilimumab × Clear all

Phase

Status

Completed 9 Recruiting 6 Terminated 4 Unknown 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 12 Carcinoma, Non-Small-Cell Lung 6 Neoplasms 4 Uveal Melanoma 3 Prostatic Neoplasms 3 Sarcoma 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Breast Neoplasms 2 Brain Neoplasms 2 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous-Cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Prostatic Diseases 1 Osteosarcoma 1 Neoplastic Cells, Circulating 1 Neoplasms, Unknown Primary 1 Neoplasms by Site 1 Nasopharyngeal Carcinoma 1 Metastatic Microsatellite Stable Colorectal Cancer 1 Kidney Neoplasms 1 Hypoxia 1 Head and Neck Neoplasms 1 Genital Neoplasms, Male 1 Gastrointestinal Stromal Tumors 1

Interventions

Sorafenib 41 lenvatinib 38 sintilimab 21 apatinib 21 camrelizumab 18 Fluorouracil 18 Oxaliplatin 16 tislelizumab 14 Hepatectomy 13 Leucovorin 12 Radiotherapy 10 Radiofrequency Ablation 10 Doxorubicin 10 toripalimab 9 Radiosurgery 9 Folfox protocol 9 Epirubicin 9 Ethiodized Oil 8 Bevacizumab 8 Neoadjuvant Therapy 7 Immune Checkpoint Inhibitors 7 regorafenib 6 pembrolizumab 6 durvalumab 6 anlotinib 6 Nivolumab 6 spartalizumab 5 entecavir 5 donafenib 5 Surgical Procedures, Operative 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03682276 2022-12-13

PRIME-HCC

Imperial College London

Phase 1/2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡